Francis Knuettel II - 11 Apr 2025 Form 4 Insider Report for Channel Therapeutics Corp (CHRO)

Role
CEO, Pres., CFO, Treas & Secty
Signature
/s/ Francis Knuettel II
Issuer symbol
CHRO
Transactions as of
11 Apr 2025
Net transactions value
$0
Form type
4
Filing time
15 Apr 2025, 21:30:47 UTC
Previous filing
04 Feb 2025
Next filing
02 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRO Stock Option Award +53,988 +14% 430,736 11 Apr 2025 Common Stock 53,988 $1.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 11, 2025, the Reporting Person was granted stock options to purchase 53,988 shares of common stock at an exercise price of $1.35 per share, which shall vest in full in the event of a change of control transaction.